Triveni Bio
Triveni Bio is a biotech company developing precision antibody treatments for immune and inflammatory disorders. The company has raised $272M in funding and employs 58 people.
The growth story
Triveni Bio grew from 3 to 58 employees between 2022 and 2026, raising $272M along the way, most recently a Series C in June 2026.
About
Triveni Bio develops antibody therapies informed by genetics and mechanistic biology, targeting immune and inflammatory disorders. Its approach focuses on establishing early proof-of-concept and expanding indications where treatments can have the most impact.
The company has raised $272M in funding, including a Series C round in 2026. With 58 employees, Triveni Bio draws talent primarily from major pharmaceutical companies and academic institutions.
Founders and leadership
Triveni Bio's largest function is Operations, with 8 employees. The company is led by a team with backgrounds in biotech and pharmaceuticals, supported by investors like Atlas Venture and FMR LLC.
The Triveni Bio org chart
Vishal Patel (Chief Executive Officer) leads 35 mapped leaders with 3 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 19 (+36% YoY), Business Development 11 (+10% YoY), Operations 6 (+100% YoY).
Talent flow
Triveni Bio recruits heavily from Sanofi, Takeda, and Pfizer, with 5, 4, and 3 hires respectively. Alumni have moved to companies like Eli Lilly and Company and Summit Therapeutics. The median tenure is 1 year.
Most common previous employers of Triveni Bio staff: Sanofi (5), Takeda (4), Pfizer (3), Novartis (3), Harvard Medical School (3), Biogen (3). Former Triveni Bio employees most often moved to City Therapeutics (1), Eli Lilly and Company (1), Summit Therapeutics (1), Alloy Therapeutics (1), Merida Biosciences (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Triveni Bio: Research Skills (19), Microsoft Office (16), Biotechnology (16), Life Sciences (14), Microsoft Excel (14), Molecular Biology (13), Microsoft PowerPoint (11), Cell Culture (11).
Where the team actually sits
Triveni Bio people are concentrated in Massachusetts, United States (27), Greater Boston (14), United States (3), Tulsa Metropolitan Area (1).
Search footprint
Triveni Bio attracts about 18 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 11 ranking keywords and lost 10 in the last period.
Frequently asked
Triveni Bio has 58 employees as of September 2026.
Triveni Bio has raised $272M in total, most recently a Series C round in June 2026.
Vishal Patel (Chief Executive Officer) sits at the top of Triveni Bio's reporting structure, with 3 direct reports.
The most common previous employers of current Triveni Bio staff are Sanofi (5 people), Takeda (4 people), Pfizer (3 people).
Former Triveni Bio employees most often move to City Therapeutics (1), Eli Lilly and Company (1), Summit Therapeutics (1).
Triveni Bio attracts about 18 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Triveni Bio staff are Research Skills, Microsoft Office, Biotechnology, Life Sciences, Microsoft Excel.
Triveni Bio staff are concentrated in Massachusetts, United States (27), Greater Boston (14), United States (3).
Triveni Bio has about 19 people in Research, up 36% over the past year, as of September 2026.
Triveni Bio has about 11 people in Business Development, up 10% over the past year, as of September 2026.
Computed from 48 current and 6 former Triveni Bio profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.